Spero named president, chief business officer at ProThera Biologics

DENICE M. SPERO has been appointed president and chief business officer of ProThera Biologics. / COURTESY PROTHERA BIOLOGICS
DENICE M. SPERO has been appointed president and chief business officer of ProThera Biologics. / COURTESY PROTHERA BIOLOGICS
PROVIDENCE – ProThera Biologics has appointed Denice M. Spero as president and chief business officer. ProThera Biologics is a biomedical company developing therapies to treat life-threatening diseases. Spero, according to the company, will strengthen its efforts to advance its inter-alpha inhibitor proteins into clinical development. She also will assume a leadership role in business development…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -